Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults

BACKGROUND: Human metapneumovirus (hMPV) and parainfluenza virus type 3 (PIV3) cause respiratory tract illness in children and the elderly. No licensed vaccines are available. METHODS: In this phase 1, randomized, dose-ranging, first-in-human study, the safety, reactogenicity, and humoral immunogeni...

Descripción completa

Detalles Bibliográficos
Autores principales: August, Allison, Shaw, Christine A, Lee, Heather, Knightly, Conor, Kalidindia, Shiva, Chu, Laurence, Essink, Brandon J, Seger, William, Zaks, Tal, Smolenov, Igor, Panther, Lori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251669/
https://www.ncbi.nlm.nih.gov/pubmed/35794943
http://dx.doi.org/10.1093/ofid/ofac206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251669/
https://www.ncbi.nlm.nih.gov/pubmed/35794943
http://dx.doi.org/10.1093/ofid/ofac206

Ejemplares similares